Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc at Nasdaq Investor Conference (Virtual) Transcript

Dec 01, 2021 / 02:30PM GMT
Release Date Price: $310.61 (-11.87%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. Hello, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. We're very pleased to have Moderna with us for this session.

Just some comments before we get started, I need to read a disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures.

Secondly, you can ask questions throughout the webcast if you would like. (Operator Instructions)

And then thirdly, so pleased to have both David Meline, the CFO from Moderna; and Paul Burton, the CMO. So we'll jump into it and looking forward to it.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

So I guess Paul, maybe just to start out, we should probably address Omicron, and just what's Moderna's outlook on Omicron just from a virus standpoint itself? And what sort of level of evidence

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot